Syzygium cumini ameliorates high fat diet induced glucose intolerance, insulin resistance, weight gain, hepatic injury and nephrotoxicity through modulation of PTP1B and PPARγ signaling
Environmental Toxicology · 2024
DOI: 10.1002/tox.23989 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Gopal Thiyagarajan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tissue Culture and Drug Discovery Laboratory, Centre for Food Technology, Department of Biotechnology, Anna University, Chennai, India. Hauptthemen laut MEDLINE: Insulin Resistance, Glucose Intolerance, Syzygium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, Government of India, UGC-SAP-DSA-I, DST-PURSE.
Abstract (Originalsprache)
Metabolic disorders are majorly associated with insulin resistance and an impaired glucose tolerance. Since, many of the currently available drugs exhibit adverse effects and are resistant to therapies, natural products are a promising alternate in the alleviation of complex metabolic disorders. In the current study, Syzygium cumini methanolic extract (SCE) was investigated for its anti‐diabetic and anti‐adipogenic potential using C57BL/6 mice fed on high fat diet (HFD). The HFD fed obese mice were treated with 200 mg/kg SCE and compared with positive controls Metformin, Pioglitazone and Sodium Orthovanadate. The biometabolites in SCE were characterized using Fourier transform infrared and gas chromatography and mass spectroscopy. A reduction in blood glucose levels with improved insulin sensitivity and glucose tolerance was observed in SCE‐treated HFD obese mice. Histopathological and biochemical investigations showed a reduction in hepatic injury and nephrotoxicity in SCE‐administered HFD mice. Results showed inhibition of PTP1B and an upregulation of IRS1 and PKB‐mediated signaling in skeletal muscle. A significant decrease in lipid markers such as TC, TG, LDL‐c and VLDL‐c levels were observed with increased HDL‐c in SCE‐treated HFD mice. A significant decrease in weight and adiposity was observed in SCE‐administered HFD mice in comparison to controls. This decrease could be due to the partial agonism of PPARγ and an increased expression of adiponectin, an insulin sensitizer. Hence, the dual‐modulatory effect of SCE, partly due to the presence of 26% Pyrogallol, could be useful in the management of diabetes and its associated maladies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tissue Culture and Drug Discovery Laboratory, Centre for Food Technology, Department of Biotechnology, Anna University, Chennai, India.
- Centre for Laboratory Animal Technology and Research, Sathyabama Institute of Science and Technology, Chennai, India.
- Department of Cell and Molecular Biology, Madras Diabetes Research Foundation, Chennai, India.
ORCID-Profile: Lakshmi Subhadra Baddireddi
Förderung
- Department of Biotechnology, Ministry of Science and Technology, Government of India
- UGC-SAP-DSA-I
- DST-PURSE
- DBT-BUILDER
Zitieren
APA
Thiyagarajan, G., Muthukumaran, P., Prabhu, D., Balasubramanyam, M., & Baddireddi, L. S. (2024). Syzygium cumini ameliorates high fat diet induced glucose intolerance, insulin resistance, weight gain, hepatic injury and nephrotoxicity through modulation of PTP1B and PPARγ signaling. Environmental Toxicology. https://doi.org/10.1002/tox.23989
Vancouver
Thiyagarajan G, Muthukumaran P, Prabhu D, Balasubramanyam M, Baddireddi LS. Syzygium cumini ameliorates high fat diet induced glucose intolerance, insulin resistance, weight gain, hepatic injury and nephrotoxicity through modulation of PTP1B and PPARγ signaling. Environmental Toxicology. 2024. doi:10.1002/tox.23989
BibTeX
@article{Thiyagarajan2024,
author = {Thiyagarajan, Gopal and Muthukumaran, Padmanaban and Prabhu, Durai and Balasubramanyam, Muthuswamy and Baddireddi, Lakshmi Subhadra},
title = {Syzygium cumini ameliorates high fat diet induced glucose intolerance, insulin resistance, weight gain, hepatic injury and nephrotoxicity through modulation of PTP1B and PPARγ signaling},
journal = {Environmental Toxicology},
year = {2024},
doi = {10.1002/tox.23989}
}
EUVIMED